LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Clinical trial NCT01345669 · TERMINATED
Trial details
- NCT number
- NCT01345669
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-17
- Primary completion
- 2016-09-12
- Enrollment
- 617
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.